KathleenSheridanDOFIDSA(She/Her)

[Pronunciation: y]

Infectious Disease Physician

Dr. Sheridan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9104 Babcock Blvd Ste 2116
Pittsburgh, PA 15237
Phone+1 412-348-0330

Fax+1 412-348-0338

UPMC Medical EducationFellowship, Infectious Disease, 2008 - 2010
Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2005 - 2008
Lake Erie College of Osteopathic Medicine - Seton HillClass of 2005

Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

PubMed

26 citations
The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive Infections.
Mark Redell, Miguel Sierra-Hoffman, Maha Assi, Markian Bochan, David Chansolme
Open Forum Infectious Diseases. 2019-11-01
40 citations
Risk Factors Associated With Outpatient Parenteral Antibiotic Therapy Program Failure Among Intravenous Drug Users.
Deanna J. Buehrle, Ryan K. Shields, Neel B Shah, Christopher Shoff, Kathleen R Sheridan
Open Forum Infectious Diseases. 2016-12-01
18 citations
Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis.
Kathleen R Sheridan, Brian A. Potoski, Ryan K. Shields, Gerard J. Nau
Pharmacotherapy. 2010-12-01